Construct: Nucleotide substitution: A?G. Nucleotide substitution: A?C. Amino acid replacement: K371A. The ap ME4 muscle enhancer drives expression of a mutated form of drl which is predicted to be catalytically inactive.
wild-type
Expression of drlK371A.ap.ME4 in a wild-type background has no effect on muscle development.
drlK371A.ap.ME4 rescues drlR343
Two copies of drlK371A.ap.ME4 completely rescue the muscle bypass phenotype of drlR343 embryos.